ArticleClinical cancer research : an official journal of the American Association for Cancer Research2013

A purine scaffold HSP90 inhibitor BIIB021 has selective activity against KSHV-associated primary effusion lymphoma and blocks vFLIP K13-induced NF-κB.

Ramakrishnan Gopalakrishnan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.